Epstein-Barr virus-based prognostic model in nodular sclerosis classic Hodgkin lymphoma.
Saved in:
| Title: | Epstein-Barr virus-based prognostic model in nodular sclerosis classic Hodgkin lymphoma. |
|---|---|
| Authors: | Jiang C; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Huang LY; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Zhou JH; Department of Hematology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, P.R. China., Li ZM; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Wang Y; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Li S; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Fu JC; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Huang QT; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Yan Q; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Huang YY; Department of Pathology, Dongguan Children's Hospital, Dongguan, Guangdong, P.R. China., Zuo M; Department of Hematology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, P.R. China., Hu S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gale RP; Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London, UK., Liang Y; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Yun JP; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Huang YH; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China. |
| Source: | IScience [iScience] 2023 Dec 18; Vol. 27 (1), pp. 108630. Date of Electronic Publication: 2023 Dec 18 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
